Splash Beverage Completes Strategic Investment in Avicanna
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 15 2026
0mins
Source: Newsfilter
- Strategic Investment Completed: Splash Beverage Group has finalized a CDN$300,000 investment in Avicanna Inc., aimed at advancing its transformation into a cannabinoid health and biopharmaceutical platform, thereby enhancing its competitive position in the market.
- Market Positioning Advantage: Avicanna is recognized as one of North America's leading cannabinoid-based biopharmaceutical companies, possessing proprietary formulations and clinical-stage pharmaceutical assets that uniquely position it for the evolving medical cannabinoid market in the U.S.
- Diverse Product Portfolio: Avicanna's portfolio includes Trunerox™, an approved cannabidiol treatment for severe epilepsy, along with multiple clinical development programs targeting pain, inflammation, and dermatological conditions, showcasing its broad application potential in the medical field.
- Strong Management Team: Avicanna boasts an experienced management team with deep expertise in healthcare, pharmaceuticals, and clinical research, coupled with a debt-free balance sheet, establishing a solid foundation for future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SBEV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SBEV
About SBEV
Splash Beverage Group, Inc. seeks to identify, acquire, and build early stage or under-valued beverage brands that have growth potential within its distribution system. The Company’s distribution system is comprehensive in the United States and is expanding to select international markets. Through its division Qplash, Splash’s distribution reach includes e-commerce access to both business-to-business (B2B) and business-to-consumer (B2C) customers. It markets beverage brands to customers throughout the United States that prefer delivery direct to their office, facilities, or homes. Its segments include Splash Beverage Group and E-Commerce. The Company's Splash Beverage Group segment includes the manufacture and distribution of non-alcoholic and alcoholic branded beverages. The E-commerce segment is engaged in the sale of e-commerce beverages. Its brands include Copa di Vino single-serve wine, Pulpoloco Sangria, SALT Tequila, and Chispo Tequila.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Splash Beverage Completes Strategic Investment in Avicanna
- Strategic Investment Completed: Splash Beverage Group has finalized a CDN$300,000 investment in Avicanna Inc., aimed at advancing its transformation into a cannabinoid health and biopharmaceutical platform, thereby enhancing its competitive position in the market.
- Market Positioning Advantage: Avicanna is recognized as one of North America's leading cannabinoid-based biopharmaceutical companies, possessing proprietary formulations and clinical-stage pharmaceutical assets that uniquely position it for the evolving medical cannabinoid market in the U.S.
- Diverse Product Portfolio: Avicanna's portfolio includes Trunerox™, an approved cannabidiol treatment for severe epilepsy, along with multiple clinical development programs targeting pain, inflammation, and dermatological conditions, showcasing its broad application potential in the medical field.
- Strong Management Team: Avicanna boasts an experienced management team with deep expertise in healthcare, pharmaceuticals, and clinical research, coupled with a debt-free balance sheet, establishing a solid foundation for future growth.
See More
Splash Beverage Submits Compliance Plan to NYSE American
- Compliance Plan Submission: Splash Beverage Group announced on Wednesday that it submitted a compliance plan to NYSE American to address listing deficiencies, filed on May 28, aimed at restoring compliance and ensuring the company's continued listing eligibility.
- Potential Cure Period: If accepted, the plan could grant Splash Beverage a cure period extending through January 29, 2027, allowing the company time to implement necessary corrective actions, thereby improving its financial standing and restoring investor confidence.
- Stock Price Volatility: Shares of Splash Beverage have lost 42% in the last month, reflecting market concerns over its compliance issues, yet the stock rose 4% in premarket trading following the compliance plan submission, indicating cautious optimism among investors regarding the company's future.
- Management Statement: The interim CEO stated that the submission of the compliance plan represents an important milestone, demonstrating the company's proactive measures to meet NYSE listing standards, which enhances market confidence in its ability to restore compliance.
See More
Splash Beverage Group Compliance Update and Strategic Transaction Progress
- Compliance Plan Submission: Splash Beverage submitted its compliance plan to the NYSE on May 28, 2026, addressing the notice received on April 29, 2026, regarding non-compliance with stockholders' equity standards; if accepted, this plan would allow the company to continue compliance initiatives until January 29, 2027, thereby maintaining its NYSE listing.
- Strategic Transaction Update: The non-binding Letter of Intent with Medterra CBD expired on May 4, 2026, and since then, Splash has actively evaluated strategic opportunities in the cannabinoid wellness sector, engaging in discussions with multiple potential counterparties to identify opportunities that align with long-term shareholder value creation.
- Going Concern Disclosure: In accordance with Section 610(b) of the NYSE American Company Guide, Splash disclosed that its audited financial statements for the fiscal year ended December 31, 2025, included an audit opinion highlighting concerns about the company's ability to continue as a going concern, fulfilling NYSE requirements without amending prior filings.
- Management Commentary: Interim CEO Brady Cobb noted that the submission of the compliance plan marks a significant milestone, with management focused on identifying opportunities that can create long-term value for shareholders, aiming to execute transactions that are strategically compelling and financially responsible.
See More
Splash Beverage Appoints New Interim CEO Amid Strategic Transition
- Leadership Change: Splash Beverage Group has appointed Brady Cobb as Interim CEO effective immediately, marking a strategic inflection point as the company transitions towards a regulated wellness and cannabinoid platform.
- Former Executive Departure: William Meissner will resign from his position as President and all other roles effective June 1, 2026, with Cobb leading the transition to ensure operational stability and compliance.
- Market Opportunities: Cobb emphasized that with the U.S. cannabis market projected to exceed $38 billion, Splash is poised to serve as a strategic bridge between emerging operators and institutional capital, capitalizing on the evolving wellness economy.
- Diverse Background: Cobb brings a multidisciplinary background in public company leadership, law, and regulatory strategy, which is expected to drive new growth momentum for the company as it navigates a rapidly changing market.
See More
Doseology Launches Innovative Energy Product Line
- Market Growth Potential: The functional market is projected to expand from $164 billion to over $240 billion, indicating strong consumer demand for utility-driven products, positioning Doseology at the forefront of this high-growth cycle.
- New Product Pilot: Doseology initiated pilot production of caffeine-based energy pouches in January 2026, utilizing nicotine-free portable packaging to meet consumer demand for healthier alternatives, which is expected to significantly enhance market competitiveness.
- Strategic Brand Acquisition: Doseology acquired the Feed That Brain brand for $400,000, integrating functional product design with market trends to strengthen its position in the energy drink and alternative caffeine product sectors.
- Executive Recruitment: The company appointed Joseph Mimran as Strategic Advisor with a three-year contract valued at $400,000, aiming to leverage his extensive retail experience to drive Doseology's product development and market expansion.
See More
Functional Beverage Market Set for Explosive Growth
- Market Surge: The global functional beverage market is projected to reach $179.26 billion by 2026, driven by health-conscious consumers shifting away from high-sugar drinks, indicating a structural reset that attracts significant capital inflow.
- New Product Pilot: Doseology Sciences launched pilot production of non-nicotine, caffeine-based energy pouches in January 2026, emphasizing predictable energy delivery to meet modern consumer demands for portable, functional beverages, which is expected to enhance market competitiveness.
- Strategic Acquisition: Doseology acquired the Feed That Brain brand for $400,000, further expanding its footprint in the functional market while appointing Joseph Mimran as Strategic Advisor to bolster product development and compliance capabilities, supporting future growth.
- Industry Collaboration: Splash Beverage Group entered a joint venture with BAAD Ventures to tap into the rapidly expanding THC beverage market, leveraging both companies' distribution networks and brand-building expertise, which is expected to significantly enhance market share and supply chain efficiencies.
See More
Splash Beverage Completes Strategic Investment in Avicanna
- Strategic Investment Completed: Splash Beverage Group has finalized a CDN$300,000 investment in Avicanna Inc., aimed at advancing its transformation into a cannabinoid health and biopharmaceutical platform, thereby enhancing its competitive position in the market.
- Market Positioning Advantage: Avicanna is recognized as one of North America's leading cannabinoid-based biopharmaceutical companies, possessing proprietary formulations and clinical-stage pharmaceutical assets that uniquely position it for the evolving medical cannabinoid market in the U.S.
- Diverse Product Portfolio: Avicanna's portfolio includes Trunerox™, an approved cannabidiol treatment for severe epilepsy, along with multiple clinical development programs targeting pain, inflammation, and dermatological conditions, showcasing its broad application potential in the medical field.
- Strong Management Team: Avicanna boasts an experienced management team with deep expertise in healthcare, pharmaceuticals, and clinical research, coupled with a debt-free balance sheet, establishing a solid foundation for future growth.
See More
Splash Beverage Submits Compliance Plan to NYSE American
- Compliance Plan Submission: Splash Beverage Group announced on Wednesday that it submitted a compliance plan to NYSE American to address listing deficiencies, filed on May 28, aimed at restoring compliance and ensuring the company's continued listing eligibility.
- Potential Cure Period: If accepted, the plan could grant Splash Beverage a cure period extending through January 29, 2027, allowing the company time to implement necessary corrective actions, thereby improving its financial standing and restoring investor confidence.
- Stock Price Volatility: Shares of Splash Beverage have lost 42% in the last month, reflecting market concerns over its compliance issues, yet the stock rose 4% in premarket trading following the compliance plan submission, indicating cautious optimism among investors regarding the company's future.
- Management Statement: The interim CEO stated that the submission of the compliance plan represents an important milestone, demonstrating the company's proactive measures to meet NYSE listing standards, which enhances market confidence in its ability to restore compliance.
See More
Splash Beverage Group Compliance Update and Strategic Transaction Progress
- Compliance Plan Submission: Splash Beverage submitted its compliance plan to the NYSE on May 28, 2026, addressing the notice received on April 29, 2026, regarding non-compliance with stockholders' equity standards; if accepted, this plan would allow the company to continue compliance initiatives until January 29, 2027, thereby maintaining its NYSE listing.
- Strategic Transaction Update: The non-binding Letter of Intent with Medterra CBD expired on May 4, 2026, and since then, Splash has actively evaluated strategic opportunities in the cannabinoid wellness sector, engaging in discussions with multiple potential counterparties to identify opportunities that align with long-term shareholder value creation.
- Going Concern Disclosure: In accordance with Section 610(b) of the NYSE American Company Guide, Splash disclosed that its audited financial statements for the fiscal year ended December 31, 2025, included an audit opinion highlighting concerns about the company's ability to continue as a going concern, fulfilling NYSE requirements without amending prior filings.
- Management Commentary: Interim CEO Brady Cobb noted that the submission of the compliance plan marks a significant milestone, with management focused on identifying opportunities that can create long-term value for shareholders, aiming to execute transactions that are strategically compelling and financially responsible.
See More
Splash Beverage Appoints New Interim CEO Amid Strategic Transition
- Leadership Change: Splash Beverage Group has appointed Brady Cobb as Interim CEO effective immediately, marking a strategic inflection point as the company transitions towards a regulated wellness and cannabinoid platform.
- Former Executive Departure: William Meissner will resign from his position as President and all other roles effective June 1, 2026, with Cobb leading the transition to ensure operational stability and compliance.
- Market Opportunities: Cobb emphasized that with the U.S. cannabis market projected to exceed $38 billion, Splash is poised to serve as a strategic bridge between emerging operators and institutional capital, capitalizing on the evolving wellness economy.
- Diverse Background: Cobb brings a multidisciplinary background in public company leadership, law, and regulatory strategy, which is expected to drive new growth momentum for the company as it navigates a rapidly changing market.
See More
Doseology Launches Innovative Energy Product Line
- Market Growth Potential: The functional market is projected to expand from $164 billion to over $240 billion, indicating strong consumer demand for utility-driven products, positioning Doseology at the forefront of this high-growth cycle.
- New Product Pilot: Doseology initiated pilot production of caffeine-based energy pouches in January 2026, utilizing nicotine-free portable packaging to meet consumer demand for healthier alternatives, which is expected to significantly enhance market competitiveness.
- Strategic Brand Acquisition: Doseology acquired the Feed That Brain brand for $400,000, integrating functional product design with market trends to strengthen its position in the energy drink and alternative caffeine product sectors.
- Executive Recruitment: The company appointed Joseph Mimran as Strategic Advisor with a three-year contract valued at $400,000, aiming to leverage his extensive retail experience to drive Doseology's product development and market expansion.
See More
Functional Beverage Market Set for Explosive Growth
- Market Surge: The global functional beverage market is projected to reach $179.26 billion by 2026, driven by health-conscious consumers shifting away from high-sugar drinks, indicating a structural reset that attracts significant capital inflow.
- New Product Pilot: Doseology Sciences launched pilot production of non-nicotine, caffeine-based energy pouches in January 2026, emphasizing predictable energy delivery to meet modern consumer demands for portable, functional beverages, which is expected to enhance market competitiveness.
- Strategic Acquisition: Doseology acquired the Feed That Brain brand for $400,000, further expanding its footprint in the functional market while appointing Joseph Mimran as Strategic Advisor to bolster product development and compliance capabilities, supporting future growth.
- Industry Collaboration: Splash Beverage Group entered a joint venture with BAAD Ventures to tap into the rapidly expanding THC beverage market, leveraging both companies' distribution networks and brand-building expertise, which is expected to significantly enhance market share and supply chain efficiencies.
See More
